Oxford Medical Simulation, a Boston- and London-based provider of AI-powered VR platforms for healthcare training, has raised £5 million ($6.6 million) in growth financing led by Salica Investments. The OMS Platform delivers immersive clinical scenarios, instant AI feedback, advanced analytics, and customization via OMS Create, enabling facilitator-free practice for nurses, doctors, and allied health professionals. The funds will accelerate AI enhancements, analytics, and workflow tools to scale clinical readiness training.
Simulation Market Grows 15.6% Annually
The raise follows a $12.6 million Series A in January 2024 led by Frog Capital. Healthcare simulation stands at $3.5 billion with a 15.6% CAGR, driven by nursing shortages and limited placements. Competitors like SimX ($2.8M raised per Crunchbase) focus on multiplayer EMS training, while FundamentalVR ($35M+ per Crunchbase) emphasizes haptic surgical sims. OMS differentiates with clinician-authored AI scenarios for broad nursing and transition-to-practice programs.
91% of Nurses Feel Unprepared
91% of graduating nurses report feeling unprepared for practice per ACF Investors. Traditional training relies on costly manikins and facilitators, yielding variable outcomes amid placement shortages. Medication errors drop 60% with OMS, and onboarding costs fall 74%, according to platform metrics. Over 150 institutions worldwide, including Johns Hopkins and University of Michigan, use OMS for scalable practice.
AI VR Delivers Instant Feedback
The OMS Platform supports VR and screen-based delivery across Mac/Windows, with AI patients responding dynamically via natural language processing. OMS Create allows educators to build custom scenarios, reducing dependency on vendor content. Unlike video-based Virti ($10M raised per Crunchbase), OMS provides fully immersive multiplayer interactions and enterprise analytics integrated with LMS systems.
FundamentalVR and ORamaVR ($4.5M seed per Crunchbase) target surgical procedures, but OMS covers general clinical skills for academic programs and health systems onboarding.
Growth Capital Signals Scale-Up
Salica Investments provides growth capital post-Series A, validating OMS's traction of 500,000+ scenarios annually and ISO 27001 compliance. This follows Memorial Hermann's co-investment in the prior round. The investor backing underscores conviction in VR's role amid workforce crises, fueling product-led expansion.
$3.5B Market Eyes AI Integration
The $3.5 billion healthcare simulation market per MarketsandMarkets grows at 15.6% CAGR, with VR/AR and AI trends dominating. OMS's 260+ scenarios align with shifts like UK's NMC allowing 600 simulation hours in training. Competitors secure funding but lack OMS's full-service implementation and 89% learner improvement rates.
Founders Bring Med Ed Expertise
Co-founders Michael Wallace (CEO) and Jack Pottle (CMO, Oxford medicine grad and ex-NHS clinician) built prior startup Oxford Medical Education. Recent hires include CFO Daniel Hines and US Sales Director, supporting dual-HQ scaling. Their clinician-led approach ensures clinical accuracy in simulations.
AI Upgrades Target US Expansion
Plans include AI-driven Hands & Voice interactions, partnerships like ASPiH, and US hires for account management. With 1 million scenarios delivered and Purdue reporting 10-15% exam pass gains, OMS eyes national rollout via health systems and universities.
As OMS CEO Michael Wallace noted:
"The work ahead is exciting, and we’re just getting started!"
Customer feedback reinforces impact:
"Learned more doing the VR scenarios than on placement."